Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125974991 | 12597499 | 1 | I | 20160630 | 20160727 | 20160727 | PER | US-PFIZER INC-2016328841 | PFIZER | 0.00 | M | Y | 0.00000 | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125974991 | 12597499 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 2700 MG, 1X/DAY | N | 20882 | 2700 | MG | FILM-COATED TABLET | QD | |||||
| 125974991 | 12597499 | 2 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 4 MG, DAILY (4 MG IN THE MORNING) | 0 | 4 | MG | |||||||||
| 125974991 | 12597499 | 3 | C | PERCOCET /00446701/ | ACETAMINOPHENOXYCODONE HYDROCHLORIDEOXYCODONE TEREPHTHALATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125974991 | 12597499 | 1 | Diabetic neuropathy |
| 125974991 | 12597499 | 2 | Diabetes mellitus |
| 125974991 | 12597499 | 3 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125974991 | 12597499 | Drug ineffective for unapproved indication | |
| 125974991 | 12597499 | Hypertension | |
| 125974991 | 12597499 | Insomnia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |